Post-earnings recap
Reported
Tue, Feb 11, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $0.73, exceeding expectations by 7.51%. However, the stock reacted negatively, declining by 0.85%. The lack of revenue data and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.73 | N/A | +7.51% |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.